Yifeng Pharmary(SH:603939) Xin Lang Cai Jing·2025-10-23 01:40Core Insights - Yifeng Pharmacy's stock price remained unchanged on October 22, with a trading volume of 129 million yuan, indicating stable market activity [1] - The company reported a financing net purchase of 980,700 yuan on the same day, reflecting a low financing balance compared to historical levels [1] - For the first half of 2025, Yifeng Pharmacy achieved a revenue of 11.722 billion yuan, a slight decrease of 0.35% year-on-year, while net profit increased by 10.32% to 880 million yuan [2] Financing and Margin Trading - On October 22, Yifeng Pharmacy had a financing buy amount of 9.0041 million yuan and a financing repayment of 8.0234 million yuan, resulting in a net financing purchase of 980,700 yuan [1] - The total financing and margin trading balance as of October 22 was 98.1041 million yuan, with the financing balance at 93.2032 million yuan, representing 0.31% of the circulating market value [1] - The company’s financing balance is currently below the 40th percentile of the past year, indicating a low level of leverage [1] Shareholder and Dividend Information - As of June 30, the number of shareholders increased by 7.70% to 21,600, while the average circulating shares per person decreased by 7.15% to 56,081 shares [2] - Since its A-share listing, Yifeng Pharmacy has distributed a total of 2.852 billion yuan in dividends, with 1.946 billion yuan distributed in the last three years [3] - The second-largest circulating shareholder is Hong Kong Central Clearing Limited, holding 237 million shares, a decrease of 35.3896 million shares from the previous period [3]